Policymakers, regulators, investors, audit committees, and audit firms all stress the importance of high-quality audits to well-functioning capital markets. Yet they acknowledge that it can be difficult to assess the performance of firms and their…
Working with the internal and external auditor
Investors have long cared about the sustainability of their portfolio companies, and climate and diversity have concerned investment managers for many years. But recent social events and the onset of COVID-19 have sharpened their focus and spurred…
Corporate and board regulatory matters, Investor perspectives on public companies
Bank and Insurance Governance Leadership Network (B/IGLN) participants met virtually on March 4 and March 11 to explore good practices for embedding diversity, equity, and inclusion into their organizations as part of the networks’ continuing focus…
Conduct and culture, Governance, Financial services leadership and talent / Banking
As the Biden administration carves out its approach to healthcare policy, some healthcare thought leaders are reflecting on the successes and failures of recent experiments in payment reform. Voluntary alternative payment models (APMs) in a range of…
New payment models, New regulatory and reimbursement approaches, Health system readiness / Healthcare
Managing the responsibilities of the audit committee is an evolving challenge for today’s audit chairs. Effective committee leadership is more important than ever, especially as proponents of governance reform continue to push for increased audit…
Board and committee effectiveness, Working with the internal and external auditor
The International Auditing and Assurance Standards Board (IAASB) develops auditing standards that can be adopted by audit regulators around the globe. It is a key player in determining how audit firms do their work, and it is continually trying to…
Accounting and financial reporting, Corporate and board regulatory matters, Working with the internal and external auditor
In 2013, the Sustainable Predictive Oncology Therapeutics and Diagnostics (SPOT/Dx) working group committed to developing a new approach to assess laboratory test validation and performance. Consequently, the Diagnostic Quality Assurance Pilot was…
Precision medicine and diagnostics / Healthcare
On January 28, 2021, Insurance Governance Leadership Network (IGLN) participants, including non-executive directors and other senior insurance leaders, were joined by EY’s insurance leaders to discuss priorities for insurance boards and management…
Governance, Regulation and supervision, Risk management and oversight / Insurance and Asset Management
A new frontier in cancer screening is leveraging liquid-based detection, which look for signals of cancer in blood, urine, or stool samples, to create multi- rather than single-cancer screens. For those organizations focused on advancing multicancer…
Precision medicine and diagnostics, Health system readiness / Healthcare
On January 21, 2021, Bank Governance Leadership Network (BGLN) participants, including non-executive directors and other senior banking leaders, were joined by EY’s banking and capital markets leaders to discuss priorities for bank boards and…
Governance, Regulation and supervision, Risk management and oversight / Banking